KVUE · News · 20260806N
Revenue Performance and Mix
Kenvue Inc. · 2026-08-06 · Importance 31 · Surprise 32 · No source text
Kenvue’s second-quarter 2026 net sales increased 3.0% year over year to $3.955 billion, compared with an analyst estimate of approximately $3.97 billion to $3.99 billion. Growth was broad-based across the Self Care, Skin Health and Beauty, and Essential Health segments. Net and organic sales increased for the third consecutive quarter across all regions, while volume growth reached 0.7%. Muted performance in the United States and Europe was offset by growth elsewhere and continued product demand for brands including Tylenol, Neutrogena, and Listerine.
Key facts
- Kenvue reported second-quarter net sales of $3.955 billion (reported elsewhere as $3.96 billion), a 3.0% year-over-year increase. source
- Kenvue reported a profit of $456 million, or $0.24 a share, in the second quarter, up from $420 million a year earlier. source
- Kenvue's stock closed at $19.18 on August 6, 2026, down 2.49% on the day. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +2.9% | Kenvue reported second-quarter net sales of $3.955 billion (reported elsewhere as $3.96 billion), a 3.0% year-over-year increase. |
| net_income | positive | realized | +0.9% | Kenvue reported a profit of $456 million, or $0.24 a share, in the second quarter, up from $420 million a year earlier. |